MedPath

山西丕康药业有限公司

Ownership
-
Established
2011-10-25
Employees
-
Market Cap
-
Website
www.sxpk.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

NMPA:10

Drug Approvals

蛭芎胶囊

Approval Number
国药准字Z20163104
Approval Date
Jul 22, 2021
NMPA

Pyrazinamide Tablets

Product Name
吡嗪酰胺片
Approval Number
国药准字H14023973
Approval Date
Apr 20, 2020
NMPA

Tiolopidine Hydrochride Capsules

Product Name
邦解清
Approval Number
国药准字H10980258
Approval Date
Apr 20, 2020
NMPA

Oryzanol Tablets

Product Name
谷维素片
Approval Number
国药准字H14023971
Approval Date
Apr 20, 2020
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H14023972
Approval Date
Apr 20, 2020
NMPA

Chlorzoxazone Tablets

Product Name
氯唑沙宗片
Approval Number
国药准字H14020826
Approval Date
Apr 20, 2020
NMPA

Compound Paracetamol and Amantadine Hydrochloride Tablets

Product Name
复方氨酚烷胺片
Approval Number
国药准字H14023974
Approval Date
Apr 20, 2020
NMPA

Multienzyme Tablets

Product Name
多酶片
Approval Number
国药准字H14023970
Approval Date
Apr 20, 2020
NMPA

Procaterol Hydrochloride Capsules

Product Name
希思宁
Approval Number
国药准字H20020464
Approval Date
Apr 20, 2020
NMPA

Aspirin and Dipyridamole Sustained Release Tablets

Product Name
阿司潘
Approval Number
国药准字H20052530
Approval Date
Apr 20, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.